The aacA-aphD aminoglycoside resistance determinant of the Staphylococcus aureus transposon Tn4OO1, which specifies resistance to gentamicin, tobramycin and kanamycin, has been cloned and shown to express these resistances in Escherichia coli. The determinant encoded a single protein with an apparent size of 59 kDa which specified both aminoglycoside acetyltransferase [AAC(6')] and aminoglycoside phosphotransferase [APH(2")] activities. Nucleotide sequence analysis of the determinant showed it to be capable of encoding a 479-amino-acid protein of 56.9 kDa. Analysis of Tn1725 insertion mutants of the determinant indicated that resistance to tobramycin and kanamycin is due to the AAC activity specified by, approximately, the first 170 amino acids of the predicted protein sequence and is consistent with the gentamicin resistance, specified by the APH activity, being encoded within the C-terminal region of the protein.
The aacA-aphD aminoglycoside resistance determinant of the Staphylococcus aureus transposon Tn4OO1, which specifies resistance to gentamicin, tobramycin and kanamycin, has been cloned and shown to express these resistances in Escherichia coli. The determinant encoded a single protein with an apparent size of 59 kDa which specified both aminoglycoside acetyltransferase [AAC(6')] and aminoglycoside phosphotransferase [APH(2")] activities. Nucleotide sequence analysis of the determinant showed it to be capable of encoding a 479-amino-acid protein of 56.9 kDa. Analysis of Tn1725 insertion mutants of the determinant indicated that resistance to tobramycin and kanamycin is due to the AAC activity specified by, approximately, the first 170 amino acids of the predicted protein sequence and is consistent with the gentamicin resistance, specified by the APH activity, being encoded within the C-terminal region of the protein.
Comparison of the C-terminal end of the predicted amino acid sequence with the reported sequences of 13 APHs and a viomycin phosphotransferase revealed a region which is highly conserved among these phosphotransferases.
I N T R O D U C T I O N
Enzymic modification of aminoglycosides is a ubiquitous mechanism of resistance to these antibiotics among clinical isolates of both Gram-negative and Gram-positive bacteria. These modifying enzymes can be plasmid-or chromosome-mediated and are often encoded on transposable elements. Three types of enzyme activity are recognized : aminoglycoside-0-phosphotransferase (APH), aminoglycoside-N-acetyltransferase (AAC) , and aminoglycoside-0-adenyltransferase (AAD). Typically, a particular enzyme catalyses a single type of modification reaction which is capable of inactivating a characteristic subset of the aminoglycosides (for reviews see Bryan, 1984; Phillips & Shannon, 1984) .
An exception to this property is the bifunctional modifying enzyme found in strains of Staphylococcus aureus, Staphylococcus epidermidis (Le Goffic et al. , 1977 ; Martel et al., 1983 ; Ubukata et al., 1984) and Streptococcus fuecalis (Courvalin et al., 1980) , which catalyses both 6'-acetyltransferase [AAC(6')] and 2'-phosphotransferase [APH(2")] reactions. These activities, which in S . aureus are encoded by a determinant designated aacA-aphD , collectively mediate resistance to the aminoglycosides gentamicin, kanamycin and tobramycin.
The composite transposon Tn4OO1, which has been responsible for the gentamicin resistance among epidemic strains of S . aureus from Australian hospitals (Lyon et al., 1984; Gillespie et al., 1987) and shares homology with a determinant which occurs in isolates from North America (Lyon et al., 1987a) , produces a similar resistance pattern to that mediated by AAC(6')-APH(2'') (1985) and subjected to alkali denaturation prior to sequencing (Chen & Seeburg, 1985 
RESULTS
Expression of Tn4001 -encoded aminoglycoside resistance in E. coli The aminoglycoside-resistance determinant of Tn4001 present on the multiresistant S. aureus plasmid pSKl has been cloned on a 2.5 kb HindIII fragment into pACYC184, forming the plasmid pSK310 (Lyon et al., 1987a) . This HindIII fragment, which consists of the 1.9 kb unique region flanked by 0.3 kb of each of the 1.35 kb IS256 copies contained within Tn4001 Lyon et aI., 1987b) , was subcloned from pSK310 into pUC8, to form plasmid pSK330 (Table 1) . The E. coli strain MC1022 harbouring pSK330 expressed Gmr, Tmr and Kmr at similar levels to those of the S. aureus strain SK2201, which carries Tn4001 located on pSKl ; minimum inhibitory concentration (MIC) values for Gm, Tm and Km for MC1022(pSK330) were 16, 32 and 256 pg ml-l, respectively. Furthermore, the 2-5 kb HindIII fragment, when recloned into the promoter-probe vector pPV33-H (West & Rodriguez, 1982) , conferred a similar level of resistance to that of pSK330, irrespective of its orientation (data not shown). Since transcriptional activity does not cross the cloning site in pPV33-H, the elements required for Gmr, Tmr and Kmr expression in E. coli are contained within the 2.5 kb HindIII fragment, Tnl725 insertion mutagenesis and deletion analysis In order to define the functional areas within the 2-5 kb HindIII fragment necessary for expression of Gmr, Tmr and Kmr, pSK330 (Table 1 ) was subjected to Tn1725 mutagenesis. Of the 22 independent insertion derivatives obtained (designated pSK343 to pSK365), 18 possessed insertions within the cloned HindIII fragment and produced four phenotypic mutant classes (Fig. 1, top) : (i) insertions at either end of the clone within IS256 sequences had no apparent effect on resistance, (ii) insertions between the arbitrary HindIII fragment coordinates 0-85-1 a20 resulted in a GmsTmsKms phenotype, (iii) insertions between coordinates 1-25-2.10 gave a Gms Tmr Kmr phenotype, and (iv) insertions mapping between coordinates 0.45-0.70 produced a low level of resistance to all three aminoglycosides (MICs being 4, 8 and 32 pg ml-1 for Gm, Tm and Km, respectively). From these results the minimum span of the coding region for Tmr and Kmr is 0.35 kb (coordinates 0.85-1-20; delineated by the insertions in pSK352 and pSK356) and the maximum span lies between coordinates 0-70-1.25 (defined by pSK351 and pSK358).
Since transcription of the area encoding the three aminoglycoside resistances most probably occurs from left to right in Fig. 1 (see below), Tn1725 insertions that are located between coordinates 0-85-2-10 and resulted in loss of Gmr (with or without corresponding loss of Tmr and Km'), may have done so for two possible reasons: they may have occurred within the structural coding region for Gmr, or, alternatively, blocked transcription into this region. The low level of resistance to all three aminoglycosides resulting from the Tnl725 insertions between coordinates 0.45-0.70 suggests that these insertions fall not within the structural coding regions, but within a region necessary for their normal expression.
To further clarify the extent of DNA required for the normal expression of aminoglycoside resistance, a series of deletions, starting at the left-hand end of the HindIII fragment (coordinate 0-0), were constructed (Fig. 1, bottom) . These were produced from plasmids containing Tn1725 insertions, by deleting the region between the EcoRI site in the pUC8 vector moiety (adjacent to the HindIII site at coordinate 0.0) and the rightmost EcoRI sites of the Tnl725; only 18 bp of the Tn1725 sequence remained after deletion (Ubben & Schmitt, 1986 deletions of the 2.5 kb HindIII fragment contained in pSK330 are designated at the lower left; the remainder of the insert fragment left after deletion is indicated. Marked at the top are the main promoter region for the determinant and the AAC(6')IV and APH(2") coding regions inferred from this and other experiments described in this study.
The region spanning coordinates 0.20-0-45, then, is important for the expression of aminoglycoside resistance, suggesting that it may contain promoter elements. The level of resistance conferred by the deletion plasmid pSK484 was fivefold lower than that of its parental plasmid, pSK345; the higher resistance encoded by the latter may be due to weak promoter activity from Tn1725 directing transcription of the aminoglycoside-resistance-coding regions.
Maxicell analysis of plasmid products The maxicell expression system was employed to examine the products encoded by the cloned Hind111 fragment and selected Tn1725 mutants (Fig. 2) . Maxicells which contained plasmids conferring wild-type resistance, viz. pSK330, pSK365 (pSK330 with Tn1725 inserted in the vector moiety), pSK343, and pSK362, produced a single insert-specific protein, estimated to be 59 kDa in size (lanes B, C, D and L, respectively), suggesting that the Gmr, Tmr and Kmr are specified by a single protein. In contrast, maxicells containing pSK348, which mediated lowlevel resistance to Gm, Tm and Km, produced the 59 kDa protein at a markedly reduced level (lane E), as did pSK351 (data not shown), indicating that the low-level resistance phenotype may result from reduced synthesis of the 59 kDa protein.
A number of the plasmids in which a Tn1725 insertion caused complete loss of one or more aminoglycoside resistances, e.g. pSK355, pSK356, pSK359 and pSK360 (lanes G, H, I, J), did riot direct synthesis of the 59 kDa protein, but specified unique proteins of 18, 20.5, 31 and 38 kDa, respectively. These products appear to be truncated forms of the 59 kDa protein. Given this, the concordant increase in size of the protein produced with increased distance of the site of Tn1725 insertion from the left, in Fig specifying GmsTmsKms phenotypes, pSK353 (lane F) and pSK354 (data not shown), failed to direct the synthesis of any detectable unique proteins. This may be due to synthesis of a product too small to be detected, since the insertions in these plasmids are close to the proposed translation initiation site for the 59 kDa protein.
Assay of am inog ly cos ide-mod $y ing enz y rnes The similarity of the resistance pattern specified by Tn4001 to that conferred by the AAC(6') and APH(2") activities encoded by S. aureus plasmids such as pSH6 (McDonnell et al., 1983) suggested that Tn400I might encode for similar aminoglycoside-modifying activities. To verify this notion, assays of aminoglycoside-modifying enzymes were performed on both S. aureus and E. coli strains harbouring plasmids carrying the determinant (Table 2 ). Plasmids pSK 1 (which carries Tn4001) and pSH6 both conferred substrate profiles specifically indicative of AAC(6')IV and APH(2") activities (Foster, 1983) ; neither specified any significant A A D activity (data not shown). The E. coli recombinant plasmid pSK330, containing the resistance determinant of Tn4001, produced AAC and APH substrate profiles essentially similar to those of pSK1, but activities were in general slightly elevated. The resistance determinant of Tn4001 appears, therefore, to encode both AAC(6') and APH(2") activities only and has, accordingly, been designated aacA-aphD.
Examination of the enzyme substrate profiles (Table 2) suggested that the AAC activity conferred Tmr and Kmr, and that the APH activity conferred Gmr. These associations were investigated further by determination of the enzyme activities specified by different classes of the Tn1725 mutants. pSK360 (GmsTmsKms) specified AAC but not APH activity, whereas pSK353 (GmsTmrKmr) did not confer AAC or APH activity. The activities of pSK344 (GmrTmrKmr) were similar to those specified by pSK330, indicating that Tn1725 insertion per se had no effect. Taken together, these results are consistent with Tmr and Kmr being due to AAC activity and with the APH activity being responsible for the Gmr.
Nucleotide sequence of the arninoglycoside-resistance determinant To further delineate the functional regions within the aacA-aphD determinant, the nucleotide sequence of the 2.5 kb Hind111 fragment encompassing the determinant was obtained from subclones of pSK330 derivatives containing Tn1725 insertions. The sequencing strategy is shown in Fig. 3 . This strategy made use of the inserted Tn1725 copies as each effectively constituted a new EcoRI site, thereby facilitating subcloning (Ubben & Schmitt, 1986) .
The sequence (Fig. 4) contains an open reading frame, bp 700-2136, of sufficient size to encode a 479-amino-acid protein of 56850 Da. This open reading frame appears to be the structural coding region for aminoglycoside resistance since Tn1725 insertions which resulted in complete loss of resistance to one or all aminoglycosides mapped within it (Fig. 1) . Furthermore, the sizes of the normal and apparent truncated forms of this protein (specified by pSK330 and Tn1725 insertion derivatives of it) predicted from the sequence were comparable to those produced in maxicells (Table 3) . For the prediction of protein sizes the contribution of Tn1725 sequences was taken into account since the translation stop codons for the reading frames entering Tn1725 occur at significant distances from the ends of the transposon (the same as for Tn1721; Schoffl et al., 1981). The hydrophilicity along the primary structure of the deduced aacA-aphD product was evenly distributed, with no large hydrophobic regions (data not shown), which is typical of soluble proteins, and is consistent with the proposed cytoplasmic location for aminoglycoside-modifying enzymes (Foster, 1983) .
The coding region which specifies the AAC activity (TmrKmr) within the aacA-aphD determinant, as deduced from the Tn1725 insertion mutagenesis, occurs at a minimum between bp 846-1200 and at a maximum between bp 700-1245 (Figs 1 and 4) . These occur in the 5'-proximal region of the aacA-aphD coding frame and thus the AAC activity is specified by between 167 and 180 amino acids at the N-terminal end of the deduced aacA-aphD product.
Aminoglycoside resistance in S . aureus 3045 * In calculation of the expected polypeptide sizes the translation start point was taken as bp 700 in the nucleotide sequence of the 2.5 kb HindIII fragment (Fig. 4) ; the translation end point for the Tn1725 insertion derivatives was determined from the sequenced site of insertion, as shown in Fig. 4 , accounting for translation read-through into Tn1725 (see text), with the exception of pSK356, where the site of Tn1725 insertion was determined by restriction mapping and the contribution of Tn1725 sequences to the expected polypeptide size was taken as the average of that predicted for the different reading frames.
7 Sizes of polypeptides produced in maxicells, as described in Fig. 2 .
$ Derivative of pSK330 with a Tn1725 insertion causing an altered aminoglycoside resistance phenotype, as described in Figs 1 and 4. Within the HindIII fragment is an unidentified reading frame (URF), 5' to aacA-aphD between bp 370-696, capable of encoding a protein of 12-6 kDa. Both the aacA-aphD reading frame and the URF, which read in the same direction, are preceded by strong ribsome-binding sites that are typical of genes from Gram-positive bacteria (McLaughlin et al., 1981) .
Upstream from the aacA-aphD coding frame are three strong potential promoter sequences. In order of decreasing fit to the E. coli promoter consensus sequence, which is the same as that of Gram-positive bacteria (McLaughlin et al., 1981 ; Moran et al., 1982) , these are P1, P2 and P3 (Fig. 4) . For example, P1 shows a five-out-of-six fit to the consensus for both the -35 and -10 boxes [the consensus being TTGACA and TATAAT, respectively (Rosenberg & Court, 1979) ] and has the optimal spacing of 17 bp between them. Both P1 and P2 occur upstream from the URF, which precedes the aacA-aphD reading frame. So, a polycistronic mRNA, encompassing the URF and aacA-aphD coding region, could possibly be initiated from P1 or P2. Interestingly, the P1 sequence lies across the boundary between the left IS256 inverted repeat and the unique central region of Tn4001 (Fig. 4). Fig. 4 (continued onJacingpage). Nucleotide sequence of the 2.5 kb HindIII fragment of Tn4002. The structural coding region for the aminoglycoside resistance gene aacA-aphD is from bp 700-2136 and the unidentified reading frame (URF) is from bp 37&696. Bold lines mark the positions of the putative promoter sequences (-10 and -35) constituting P1, P2 and P3 and potential ribosome-binding sites (RBS) for the resistance gene and the URF. The positions of Tn2725 insertions mapped by sequencing are indicated by squares and associated (pSK) plasmid numbers; corresponding aminoglycosideresistance phenotype symbols are as shown in Fig. 1 . The region of the aacA-aphD predicted amino acid sequence with major homology to those of other APHs (Fig. 5 ) G~;'rGC'rC'rTrAG'rCGAT'rCTGGGAATTTCCTTCCTTGTAC~GTATATTGAAAGGCGTCTTCGAATCCATCATCCAATGAT~~~~ MCCTT
D . A . R O U C H AND O T H E R S
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DNA homology
The nucleotide sequence of the aacA-aphD region is almost identical to that of a Streptococcus faecalis plasmid determinant which similarly encodes for AAC(6')-APH(2") activities (Ferretti et al., 1986) . Within the sequenced region of the Strep. faecalis determinant, starting at the equivalent of bp 396 of the S . aureus sequence and ending at the right-hand Hind111 site, the only differences are a 1 bp deletion in the Strep. faecalis sequence compared to the S . aureus sequence at bp 446 and a relative transversion at bp 2157, with A and C occurring in the Strep. faecalis and S . aureus sequences, respectively. The deletion causes a frameshift in the URF of one sequence compared to the other, and the base pair difference is downstream from the region encoding the AAC(6')-APH(2") activities. The inferred primary structures of the AAC(6')-APH(2") proteins from S. aureus and Strep. faecalis are, therefore, identical. Gray & Fitch (1983) and Trieu-Cuot et al. (1985) , respectively; for the Bacillus circulans APH(3')(5")IV from Herbert et al. (1983) ; for the Streptomyces fradiae APH(3')(5")V from Thompson & Gray (1983) ; for the APH (4) Polypeptide primary structure homology A comparison of the deduced amino acid sequence of the aacA-aphD product with that of other sequenced resistance genes revealed a region of approximately 40 amino acids (368-408) near the C-terminus which is conserved with other APHs and a viomycin phosphotransferase (VPH) (Fig. 5) . This suggests that the C-terminal region of the aacA-aphD product is responsible for the APH(2") activity and that the conserved residues represent active-site sequences. The conserved asparagine residues (D), being anionic, may be involved in binding of the cationic aminoglycoside substrates. Although there are further sequence positions at which the phosphotransferases show strong homology, these are scattered.
Significant homology was also found between the deduced primary structure of the aacAaphD product and that of the streptothricin acetyltransferase from Streptomyces lavendulae (Horinouchi et al., 1987) , between amino acids 110-153 in the AAC(6') region; no significant homology was found with other sequenced acetyltransferases, which include the AAC(3)III and IV of E. coli (Brau et al., 1984; Allmansberger et al., 1985) and the chloramphenicol acetyltransferases (CATS) type I and I11 from E. coli (Shaw et al., 1979 ; L. Packman, N. Kaye & S. Fitton, unpublished results, cited in Shaw, 1983 ) and type C and pC194 from S. aureus (Shaw et al., 1985; Byeon & Weisblum, 1984) . Ferretti et al. (1986) noted homology between the amino acid sequences of the AAC(6')-APH(2") and the CAT from Bacilluspumilus (Harwood et al., 1983) ; our analysis, however, did not register sequence conservation in this case (amino acid identity was less than 30%).
Secondary structure analysis of the aacA-aphD product Ferretti et al. (1986) attempted to subclone the APH(2") domain separately from the Strep. faecalis AAC(6')-APH(2"), which has an identical predicted sequence to that of the aacA-aphD product, and found that APH activity could only be expressed if most of the N-terminal region, specifying the AAC(6') activity, was present in addition to the C-terminal region proposed to specify the APH(2") activity; a protein shortened at the N-terminal end by 12% but not 50%
Aminoglycoside resistance in S . aureus 3049 expressed APH activity. Examination of the putative secondary structure of the protein offers an explanation for this; viz., that the C-terminal region takes up a different secondary structure in the whole AAC(6')-APH(2") protein compared to when it is present in a significantly truncated form (data not shown). Only truncated AAC(6')-APH(2'') polypeptides with less than approximately 18% deleted from the N-terminal end should possess the conformation of the Cterminal domain generated for the wild-type protein, a prediction entirely consistent with the results of Ferretti et al. (1986) .
DISCUSSION
We report here a genetic and biochemical analysis of the resistance to gentamicin, tobramycin and kanamycin encoded by the transposon Tn4001 from S . aureus. Resistance to these aminoglycosides involves AAC and APH modifying enzyme activities, and substrate profiles imply these to be AAC(6')IV and APH(2") activities, respectively. These activities, which are detected together in staphylococci and streptococci, are specified by a single bifunctional enzyme in the cases of S. aureus strains containing plasmids RPAL or pTU053 (Martel et al., 1983; Ubukata et al., 1984) , S . epidermidis strain TK1265 (Ubukata et al., 1984) and Strep. faecalis strains harbouring pIP800 (Courvalin et al., 1980; Ferretti et al., 1986) . Likewise, the AAC and APH activities encoded by Tn4001 are also specified by a single enzyme, since expression analysis of the 2.5 kb Hind111 fragment from Tn4001 [which contains the determinant for AAC(6') and APH(2") activities, designated aacA-aphD], and Tnl725 mutants of it, demonstrated that a single protein with an apparent size of 59 kDa is associated with the activities. This is similar to the sizes reported for purified AAC(6')-APH(2")s (54-56 kDa; Martel et al., 1983; Ubukata et al., 1984) , and is consistent with the nucleotide sequence data, which indicate a polypeptide of 56.9 kDa to be involved.
Additionally, an unidentified reading frame (URF), capable of specifying a 12 kDa protein, occurs 5' to the aacA-aphD coding area. This region does not, however, appear to be involved in the aminoglycoside resistance since the corresponding region in the nearly identical AAC(6')-APH(2") determinant from Strep. faecalis plasmid pIP800 (Ferretti et al., 1986) contains a frameshift relative to that of Tn4001.
There are a number of potential promoter sequences 5' to the aacA-aphD coding frame. Of these, the two strongest, PI and P2, lie within the area, bp 197-441, defined by the Tn1725 insertion and deletion analysis as being important for expression of aminoglycoside resistance. In contrast, Ferretti et al. (1986) suggested that the promoter for the streptococcal AAC(6')-APH(2") determinant occurs at a position corresponding to bp623-654 in the S. aureus sequence. However, deletions of the aacA-aphD region starting at the left-hand Hind111 site with their end-points occurring 3' to bp 441 resulted in aminoglycoside resistance being expressed at greatly reduced levels, indicating that the Pl/P2 region is more likely to be the main promoter region for aacA-aphD; conclusive identification of promoter elements awaits transcript analysis. The area between bp 441 and the beginning of the aacA-aphD coding frame, at bp 700, contains P3, which has a slightly lesser fit to the promoter consensus sequence than P1 and P2, and a number of much weaker potential promoters. These promoters may be responsible for the low level of aminoglycoside resistance remaining when the region is deleted or when transcription from P1/P2 is blocked with a Tn1725 insertion.
Characterization of Tn1725 insertions in aacA-aphD indicates that 167-1 80 codons from the 5' end of the structural coding region are sufficient to specify the AAC activity, whereas the remaining 3' portion of the gene presumably encodes the APH activity. These results are consistent with the contention that the AAC and APH activities are specified by separate domains in the aacA-aphD product, and in full support for this Martel et al. (1983) have demonstrated that the AAC and APH active sites of the AAC(6')-APH(2") enzyme encoded by the S. aureus plasmid RPAL occur at two separate locations. As such, it has been suggested that the bifunctional enzyme resulted from the fusion of two genes encoding an AAC(6') and an APH(2") (Martel et al., 1983; Ferretti et al., 1986) . If so, then the failure of the APH domain to specify activity when detached from the AAC domain (Ferretti et al., 1986) implies that the APH domain has undergone structural alteration since the fusion event.
D . A. ROUCH A N D OTHERS
It has been proposed that some resistance mechanisms found in clinical bacterial isolates originated in the antibiotic-producing soil bacteria (Benveniste & Davies, 1973 ; Koch, 1981 ; Gray & Fitch, 1983) . It is, therefore, of interest that AAC(6') activity with a substrate profile similar to that of the AAC(6')IV of Tn4001 is found in the kanamycin producer Streptomyces kanamyceticus (Benveniste & Davies, 1973) . However, comparison of the G + C contents of Streptomyces and the aacA-aphD region of Tn4001, which are 69-73 % and 26%, respectively, indicates that Streptomyces is unlikely to be the immediate origin of the aacA-aphD gene. A possibility, then, is that the direct source of the aacA-aphD gene is a soil organism with a low G + C content, such as a Bacillus, that cohabits with an aminoglycoside producer. In contrast to the aacA-aphD region, with a 26% G + C content, the sequenced portions of the inverted repeat (IS256) sequences which flank this region on Tn4002 have a 47% G + C content. This is suggestive of different origins for the IS256 elements and the aacA-aphD determinant of Tn4002.
Enzymes which confer antibiotic resistance in vivo may have evolved from preiexisting cellular enzymes (Koch, 198 1 ; Samraoui et al., 1986) . Known families of nucleotide-binding proteins and phosphotransferases (kinases) were, therefore, examined for sequence homology with the predicted sequence of the AAC(6)-APH(2") and other APH enzymes, but no significant homology was detected, suggesting that the APH(2") of the bifunctional enzyme and related APHs (Fig. 5 ) represent a new class of kinases. They may have all evolved from an as yet unidentified cellular kinase.
Comparison of the AAC(6') sequence with that of a streptothricin acetyltransferase revealed a significant region of homology, which may thus correspond to the binding site for their common co-factor, ace tyl-CoA.
The nucleotide sequence of the aacA-aphl) determinant and flanking regions is almost identical to that of the AAC(6')-APH(2") determinant of Strep. faecalis plasmid pIP800. Since the aacA-aphD determinant is flanked by the IS256 sequences of Tn4O02, the result suggests that the Strep. faecalis determinant is also flanked, at least on the side that has been sequenced, by a copy of IS256. That is, a Tn4002-like element also occurs in Streptococcus. This implies the possibility that all cases of AAC(6')-APH(2") activities, which have been documented only in staphylococci and streptococci, are due to the presence of Tn4001-like elements. Consistent with this notion is the presence of DNA homologous to Tn4001 in all gentamicin-resistant S. aureus strains which we have examined (Lyon et al., 1987a; Gillespie et al., 1987) .
Being only 4.7 kb in size, Tn4002 is one of the smallest transposons encoding multiple antibiotic resistance, in part due to the bifunctional nature of the single resistance protein that it encodes. Such a transposon appears to be particularly suited for dissemination on nonconjugative plasmids via transduction, with its intrinsic size limitation, as well as on conjugative plasmids. It is not surprising, therefore that Tn4002-like elements have been detected on both types of plasmids, spreading via non-conjugative plasmids in Australian isolates and via both conjugative and non-conjugative plasmids in North American isolates .
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